Patterns of Pharmacotherapy and Treatment Response in Elderly Adults with Bipolar Disorder
By John L. Beyer, MD, Bruce Burchitt, PhD, Kenneth Gersing, MD, and K. Ranga R. Krishnan, MD
Clinical and Pharmacoeconomic Evaluation of Switch to Olanzapine in Veterans with Schizophrenia or Schizoaffective Disorder
By Lori L. Davis, MD, Marshall E. Cates, PharmD, BCPP, FASHP, Joette S. Lowe, PharmD, L. Charles Ward, PhD, Jeffrey D. Johnson, RN, BSN, Raela B. Williford, PharmD, Sandra M. Ambrose, MSN, Brandi L. Thomas, LCSW, and Terrell Michael Kashner, PhD, JD, MPH
Psychopharmacotherapy in Eating Disorders: A Systematic Analysis
By A. Riedl, MD, J. Becker, PhD, M. Rauchfuss, MD, and B.F. Klapp, MD
Concordance with Treatment Guidelines for Bipolar Disorder: Data from the Systematic Treatment Enhancement Program
for Bipolar Disorder
By Ellen B. Dennehy, PhD, Mark S. Bauer, MD, Roy H. Perlis, MD, Jane N. Kogan, PhD, and Gary S. Sachs, MD
Simple Options for Improving Signal Detection in Antidepressant Clinical Trials
By Craig H. Mallinckrodt, PhD, Adam L. Meyers, MS, Apurva Prakash, BA, Douglas E. Faries, PhD,
and Michael J. Detke, MD, PhD
Current Approaches to the Pharmacologic Treatment of Anxiety Disorders
David V. Sheehan, MD,MBA and Kathy Harnett Sheehan, PhD
Rational Antidepressant Selection: Applying Evidence-Based Medicine to Complex Real-World Patients
By Mark Zetin, MD, Cara T. Hoepner, RN, and Lynda Bjornson, PhD
Contacts
in Evidence-Based Medicine
|
Post a Comment